ABEONA THERAPEUTICS INC. Inventory
ABEONA THERAPEUTICS INC. (ABEO) had Inventory of $5.92 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-13
- 2026-06-30: Inventory, Net $5.92M.
- 2026-03-31: Inventory, Net $6.05M.
- 2025-12-31: Inventory, Net $5.49M.
- 2025-09-30: Inventory, Net $4.85M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $5.92M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.05M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.49M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $4.85M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.69M 10-Q · filed 2025-08-14 |
| 2013-12-31 | $0.00 10-K · filed 2014-03-26 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 |
| 2013-03-31 | $150.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $194.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | $236.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $281.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $97.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $151.00K 10-K · filed 2013-03-20 |
| 2011-09-30 | $192.00K 10-Q · filed 2011-11-14 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |